BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.;CORIC Vladimir
发明人:
CORIC Vladimir
申请号：
IL26284918
公开号：
IL262849D0
申请日:
2018.11.07
申请国别(地区):
IL
年份:
2018
代理人:
摘要：
Disclosed are methods of treating cancer using a combination of an immunotherapeutic agent, such as, for example, a PD-1, PD-L1 or CTLA-4 checkpoint inhibitor, and a glutamate modulating agent such as riluzole or trigriluzole. Pharmaceutical compositions including the immunotherapeutic agents and glutamate modulating agents are also disclosed.
